License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Phase 3 Multicenter Randomized Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Adolescent Subjects With Moderate to Severe Plaque-type Psoriasis

The primary objectives of this study are to evaluate the efficacy and safety of 2 SC dosing tiers of ustekinumab in the treatment of adolescent subjects 12 to 18 years of age with moderate to severe chronic plaque psoriasis

FieldValue
Modified
2019-10-30
Release Date
2019-04-19
Identifier
04a5c8cf-e4a0-439a-a4ec-a39a143cad1e
License
License Not Specified
Public Access Level
Public